Document Detail


Protection of mouse heart against hypoxic damage by AMP deaminase inhibition.
MedLine Citation:
PMID:  20544535     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Clinical observation in patients with heart disease indicates that reduced activity of AMP deaminase could be protective in heart failure and ischemic heart disease. This study evaluated the effect of 3-[2-(3-carboxy-4-bromo-5,6,7,8-tetrahydronaphthyl)ethyl]-3,6,7,8-tetrahydroimidazo [4,5-d][1,3]diazepin-8-ol, an AMP deaminase inhibitor (AMPDI) in the mouse heart subjected to hypoxia. ApoE/LDLR knock-out mice were subjected to reduced oxygen tension in breathing air. AMPDI was infused before hypoxia in the treated group. We observed amelioration of elcetrocardiographic changes during hypoxia in the treated group that are consistent with a protective effect.
Authors:
T Borkowski; E M Slominska; C Orlewska; S Chlopicki; P Siondalski; M H Yacoub; R T Smolenski
Related Documents :
7545515 - Involvement of protein kinase c in the delayed cytoprotection following sublethal ischa...
9476575 - An atp-sensitive potassium (katp) channel opener, nicorandil, lowers the threshold for ...
12460865 - Transient limb ischemia induces remote ischemic preconditioning in vivo.
2060105 - Protection against infarction afforded by preconditioning is mediated by a1 adenosine r...
17448725 - Mechanisms, prediction and treatment of ventricular tachyarrhythmias occurring late aft...
23637335 - Elastogenesis at the onset of human cardiac valve development.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Nucleosides, nucleotides & nucleic acids     Volume:  29     ISSN:  1532-2335     ISO Abbreviation:  Nucleosides Nucleotides Nucleic Acids     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-06-14     Completed Date:  2010-09-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100892832     Medline TA:  Nucleosides Nucleotides Nucleic Acids     Country:  England    
Other Details:
Languages:  eng     Pagination:  449-52     Citation Subset:  IM    
Affiliation:
Department of Biochemistry, Medical University of Gdansk, Poland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
AMP Deaminase / antagonists & inhibitors*
Animals
Anoxia / drug therapy*
Enzyme Inhibitors / therapeutic use*
Mice
Mice, Knockout
Chemical
Reg. No./Substance:
0/Enzyme Inhibitors; EC 3.5.4.6/AMP Deaminase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Nucleoside phosphorylases from clostridium perfringens in the synthesis of 2',3'-dideoxyinosine.
Next Document:  Cardiac Muscle AMP-Deaminase from a 10-Year-Old Male Heterozygous for the AMPD1 C34T Mutation.